Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 58
Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel.
Times cited: 14
- Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions.
The Journal of urology.
Times cited: 6